Biological Sample Collection Kits Market - By Product (Swabs, Viral Transport Media, Blood Collection Kits, Urine Collection Kits), Application (Diagnostics, Research), End-use (Hospitals and Clinics, Diagnostic Centers, Homecare) & Forecast, 2024 – 2032

Biological Sample Collection Kits Market Size

Biological Sample Collection Kits Market size was valued at USD 8.4 billion in 2023 and is expected to exhibit growth at a CAGR of 8.8% from 2024 to 2032, driven by the increasing number of laboratory tests, fueled by rising chronic and infectious disease prevalence, advancements in diagnostic technologies, and a growing emphasis on personalized medicine.
 

Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring, which drives demand for diagnostic tests. As healthcare providers, researchers, and diagnostic labs seek reliable, efficient, and high-quality kits to meet these expanding needs, the market continues to experience robust growth. Biological sample collection kits are specialized tools designed to safely and effectively collect, preserve, and transport biological specimens for laboratory analysis. These kits play a vital role in biomedical research, clinical diagnostics, and healthcare settings, where precise and reliable sample analysis is crucial for accurate results and effective patient care.
 

Biological Sample Collection Kits Market Trends

Ongoing R&D investments and innovations in biological sample collection kits are enhancing their ability to collect high-quality samples across various settings. These advancements support the growing need for personalized medicine and improve the efficiency of diagnostic and research processes.
 

• Modern innovations ensure better preservation and stability of biological samples, which is essential for accurate analysis. By reducing the risk of sample degradation and contamination, these improvements lead to more reliable diagnostic and research outcomes. 
   
• Microfluidic technology, for instance, enables the precise collection and processing of small sample volumes. Devices utilizing this technology allow for painless finger-prick blood sampling with integrated processing capabilities. Similarly, dried blood spot (DBS) cards have benefited from advancements that improve the formulation of filter paper, enhancing the stability and recovery of analytes from dried blood spots. These cards simplify the collection and storage of blood samples at room temperature.
   
• Furthermore, non-invasive saliva collection kits have also seen significant improvements, making them more reliable for detecting a broad range of biomarkers, including genetic material for DNA/RNA analysis and hormones for endocrinological studies. Collectively, these innovations contribute to the increased demand for biological sample collection kits in the market by improving sample quality, ease of collection, and analytical accuracy.
   

Biological Sample Collection Kits Market Analysis

Based on product, the market is categorized into swabs, viral transport media, blood collection kits, urine collection kits, and other products. The swabs segment generated the highest revenue of USD 2.2 billion in 2023.
 

• Swabs are user-friendly and minimally invasive compared to more complex sample collection methods, such as blood draws. This ease of use makes them ideal for widespread screening and at-home testing.
   
• Additionally, swabs are versatile tools used for collecting samples from various body sites, including oral, nasal, vaginal, and wound areas. Their broad application in diagnostics further drives their demand in the market.
   

Based on application, the biological sample collection kits market is classified into diagnostics, and research. The diagnostics segment dominated the market in 2023 with a market share of 78.8%.
 

• The increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer necessitates regular monitoring and diagnostic testing. This ongoing need for disease management drives substantial demand for diagnostic tests.
   
• Additionally, early detection through routine diagnostics improves management and treatment outcomes, further underscoring the critical role of these tests in effective healthcare.
   

Based on end-use, the biological sample collection kits market is classified into hospitals and clinics, diagnostic centers, homecare, and other end-users. The hospitals and clinics segment dominated the market and is expected to grow at a pace of 8.7% CAGR between 2024 – 2032.
 

• Hospitals and clinics experience a high volume of patient visits for a range of health issues, including acute and chronic conditions, routine check-ups, surgeries, and emergencies. This generates a continuous and significant demand for biological sample collection kits.
   
• Additionally, the provision of both inpatient and outpatient services in these facilities addresses a diverse range of diagnostic and therapeutic needs, ensuring a steady requirement for sample collection kits for both immediate and scheduled testing.
   

North America biological sample collection kits market accounted for USD 2.7 billion market revenue in 2023 and is anticipated to grow at CAGR of 8.1% between 2024 – 2032 period.
 

• North America has a high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer. Regular monitoring and diagnostic testing for these conditions drive the demand for sample collection kits.
   
• For instance, according to the Centers for Disease Control and Prevention (CDC), as of 2020, approximately 34.2 million Americans had diabetes. Increase in prevalence of such conditions is driving the market growth in the region.
   

The U.S. held a dominant position in the biological sample collection kits market, with a revenue of USD 2.5 billion in 2023.
 

• Increased awareness and emphasis on preventive healthcare in the country lead to more routine screenings and early detection programs, requiring various sample collection kits.
   
• Moreover, public health campaigns and initiatives promoting regular health check-ups and screenings contribute to the rising demand for diagnostic testing supplies.
   

Germany biological sample collection kits market is projected to grow remarkably in the coming years.
 

• Germany has a well-developed healthcare infrastructure with numerous hospitals, clinics, and diagnostic centers that require a steady supply of sample collection kits.
   
• Additionally, regulatory agencies like the European Medicines Agency (EMA) and national bodies provide clear guidelines and approvals for diagnostic tests and sample collection kits, ensuring market growth and trust in these products.
   

Japan holds a dominant position in the Asia Pacific biological sample collection kits market.
 

• Japan is a leading hub for biomedical research and clinical trials, which require extensive use of biological sample collection kits for various studies.
   
• Additionally, numerous academic and research institutions involved in cutting-edge research drive the demand for specialized sample collection kits.
   

Biological Sample Collection Kits Market Share

The market is experiencing significant growth due to rising global prevalence of respiratory disorders, fuelled by factors such as aging populations and lifestyle changes. Key players, including healthcare providers, and medical device manufacturers, drive innovation with technologies. Initiatives in collection kits, systems, consumables and personalized healthcare are reshaping the landscape, emphasizing early detection and tailored treatment approaches. As demand for accurate sample collection kits continues to escalate, market expansion, collaboration, and investment in advanced solutions are key strategies for industry players.
 

Biological Sample Collection Kits Market Companies

Prominent players operating in the biological sample collection kits industry include:

• Abbott Laboratories
• Altona Diagnostics GmbH
• Becton, Dickinson and Company
• CTK Biotech, Inc.
• F. Hoffmann-La Roche Ltd
• Hardy Diagnostics
• HiMedia Laboratories
• Laboratory Corporation of America Holdings
• Lucence Health Inc.
• Medline Industries, Inc.
• Miraclean Technology Co. Ltd
• Puritan Medical Products
• QIAGEN
• Seegene Inc.
• Thermo Fisher Scientific, Inc.
• VIRCELL S.L.
   

Biological Sample Collection Kits Industry News:

• In June 2022, altona Diagnostics GmbH launched the RealStar Zoonotic Orthopoxvirus PCR Kit 1.0, a real-time RT-PCR reagent system. This introduction bolstered the company’s market competitiveness and enhanced its reputation.
   
• In July 2021, Abbott Launched Panbio COVID-19 Antigen Self-Test in India; expanding its rapid diagnostics portfolio to meet testing needs. This launch not only contributed to the company’s revenue but also significantly grew its customer base.
   

The biological sample collection kits market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Swabs
  • Nasopharyngeal (NP) swabs
  • Oropharyngeal (OP) swabs
  • Nasal swabs
• Viral transport media
• Blood collection kits
• Urine collection kits
• Other products

Market, By Application 

• Diagnostics
• Research

Market, By End-use

• Hospitals and clinics
• Diagnostic centers
• Homecare
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa